Filing Details

Accession Number:
0001415889-23-003907
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-02 19:35:15
Reporting Period:
2023-02-28
Accepted Time:
2023-03-02 19:35:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565892 Funck, Jr. Robert E. 100 Abbott Park Road
Abbott Park IL 60064
Executive Vice President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Disposition 2023-02-28 11,500 $99.77 219,501 No 4 F Direct
Common Shares Without Par Value Disposition 2023-03-01 1,264 $100.70 218,237 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 10,000 Indirect By Trust
Common Shares Without Par Value 10,000 Indirect By Trust
Common Shares Without Par Value 18,405 Indirect Profit Sharing Trust
Common Shares Without Par Value 500 Indirect By Daughter
Footnotes
  1. Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
  2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
  3. The reporting person disclaims beneficial ownership of all securities held by his daughter.